Cancer Drug Trial – Dostarlimab
June 15 , 2022
768 days
1132
- A trial of a drug for cancer treatment has shown 100% success in removing the tumours and preventing recurrence in patients.
- A trial was held in Manhattan, USA.
- The medication aimed to unmask cancer cells, allowing the body’s immune system to identify and destroy them naturally.
- Such drugs, known as ‘checkpoint inhibitors.
![](https://www.tnpscthervupettagam.com/assets/home/media/general/original_image/15-722.jpg)
Post Views:
1132